A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.
The result of the team’s four-year project is a novel gene therapeutic approach. The work was published (http://stm.sciencemag.org/content/8/348/348ra98) July 20 in Science Translational Medicine, a journal of the American Association for the Advancement of Science.
“Chronic disease affects more than half of the world’s population,” said Rodgers, professor of animal sciences (https://ansci.wsu.edu/people/faculty/dan-rodgers/) and director of the Washington Center for Muscle Biology (http://wcmb.wsu.edu/). “Most of those diseases are accompanied by muscle wasting.
“It occurs with chronic infection, muscular dystrophy, malnutrition and old age,” he said. “About half the people who die from cancer are actually dying from muscle wasting and there’s not one single therapy out there that addresses it.
Family history inspires search for treatment
“I have a strong motivation to do something about this, to do more than simply publish results,” said Rodgers, who teamed with Gregorevic of Baker IDI Heart and Diabetes Institute in Australia (https://www.bakeridi.edu.au/). “My father died from cachexia,” the wasting disease caused by cancer, “and my nephew has Duchenne muscular dystrophy, an incurable, fatal disease that could claim his life in his teens.
“Others have tried and failed to develop treatments for muscle wasting,” Rodgers said, “and some drugs have even caused serious safety problems. Our targeted approach only affects muscle and completely avoids these problems, which is why we think we have a solution.”
In the paper, lead author Catherine Winbanks, a postdoctoral fellow of Gregorevic, details how researchers built muscle in healthy mice and prevented the loss of skeletal and heart muscle in mice with tumors.
Hormone’s muscle-wasting effect blocked
In cachexia, tumors secrete hormones that cause muscle deterioration; in effect, the body eats its own muscles, causing weakness, frailty and fatigue.
“What kills a lot of people isn’t the loss of skeletal muscle but heart muscle,” said Rodgers. “The heart literally shrinks, causing heart failure.”
Researchers have long sought to stop this process, but failed to find a safe way. That’s because the hormones that cause wasting – in particular, a naturally occurring hormone called myostatin – play important roles elsewhere in the body.
Rodgers and Gregorevic needed a way to stop myostatin, but only in muscles. Their solution: an adeno-associated virus – a benign virus that specifically targets heart and skeletal muscle.
The virus delivers a small piece of DNA – a signaling protein called Smad7 – into muscle cells. Smad7 then blocks two signaling proteins called Smad2 and Smad3, which are activated by myostatin and other muscle-wasting hormones. By blocking those signals, Smad7 stops the breakdown of muscles.
“Smad7 is the body’s natural break and, by inhibiting the inhibitor, you build muscle,” Rodgers said.
For cachexia patients, such a therapy could massively increase their chances of survival.
“Instead of having one year to fight cancer, you’d have 10 or 15,” Rodgers said.
Startup works to develop commercial drug
In 2015, Rodgers launched AAVogen, a company that will develop this discovery into a commercial drug, AVGN7.
He has been working with Norman Ong, a technology licensing associate at WSU’s Office of Commercialization, on patents, startup funding and recruitment for AAVogen. Using the funds from WSU’s commercial gap fund award, Rodgers’ lab will determine the minimum effective dose for AVGN7.
“We want to turn WSU discoveries into real-world uses that benefit the public,” said Ong. “Dan is a very busy scientist, so we’re proud to help him and AAVogen connect with the right people.”
“I formed this company for one purpose: to move the science into society, to see it applied,” Rodgers said. “WSU’s Office of Commercialization has been instrumental and invaluable to this endeavor.
“Now we have a company with the potential to save a lot of lives,” he said.
Learn more: Scientist develops gene therapy for muscle wasting
The Latest on: Muscle wasting
[google_news title=”” keyword=”Muscle wasting” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Muscle wasting
- Girl, 3, crawls for the first time & stuns doctors who said she would be in a wheelchair for lifeon May 12, 2024 at 2:42 pm
A TOT with a rare muscle-wasting disease has crawled for the first time – stunning medics who said she would be confined to a wheelchair for life. Little Willow Christie, three, has raised ...
- Jerry R. Mendell makes TIME100 Health list for pioneering researchon May 10, 2024 at 6:21 am
Jerry R. Mendell, MD, has been named to the TIME100 Health list for his contributions to the treatment of neuromuscular diseases.
- Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected To Reach $3.3 Billion In 2024 - Financial News Mediaon May 8, 2024 at 11:58 am
( MENAFN - Financial News Media) data-id="165ecfe1" data-element_type="widget" data-widget_type="theme-post-content"> Palm Beach, FL – May 8, 2024 – FN Media Group News Commentary – There is much ...
- Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trialon May 8, 2024 at 8:09 am
A young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene therapy in a mid-stage trial for Duchenne muscular dystrophy (DMD), the company told in a letter to ...
- Pfizer reports patient death in Duchenne gene therapy studyon May 7, 2024 at 2:49 pm
A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular dystrophy(DMD), ...
- What is Ostarine? The PED Ryan Garcia tested positive for after fight with Devin Haney known for its therapeutic and muscle building propertieson May 2, 2024 at 9:46 am
However, according to the USADA, Ostarine is being investigated as a way to treat 'muscle-wasting diseases' like osteoporosis, cancer, and hypogonadism. Why do athletes use it? According to WebMD, ...
- Here are 3 ways to retain your muscles post-surgery or injuryon May 2, 2024 at 2:02 am
There are few things you can do to make sure your recovery and return to pre-surgery ability are as efficient as possible post-surgery or injury.
- Mum of tot with 'death sentence' muscle wasting condition makes every day counton May 1, 2024 at 7:44 am
Jack Trudel, five, was diagnosed with Duchenne's Muscular Dystrophy (DMD) at birth - a muscle wasting condition that causes progressive muscle weakness, and his mum says it's a "death sentence ...
- HMB Is Tiktok’s New Muscle Building Supplement. Does It Work?on April 30, 2024 at 10:17 am
“In human and animal studies, HMB has been shown to activate mTOR, a protein that tells the body to make more muscle,” she says. “At the same time, HMB suppresses certain systems that break down ...
- How much protein do you need to build muscle?on April 28, 2024 at 1:29 am
As you get older, muscle mass decreases (called muscle atrophy) and so does your metabolism, so consuming enough protein becomes even more important. The more you grow, the more you’ll need to ...
via Bing News